financetom
Business
financetom
/
Business
/
IDFC appoints Mahendra Shah as MD & CEO effective from October 1
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
IDFC appoints Mahendra Shah as MD & CEO effective from October 1
Aug 24, 2022 8:29 AM

Private lender IDFC on on August 24 said it has appointed Mahendra Shah as managing director and chief executive officer with effect from October 1, 2022, till September 30, 2023, subject to the approval of the shareholders.

Share Market Live

NSE

Shah will replace incumbent MD and CEO Sunil Kakar, whose term will end on September 30, 2022, the company said in an exchange filing.

Shah was the group company secretary and group compliance officer of IDFC FIRST Bank Ltd and has been the group head — governance, compliance and secretarial and senior advisor — taxation at IDFC Ltd for more than a decade.

Also Read: After selling tickets worth Rs 300 cr in 10 days, EaseMyTrip says 'pent-up demand yet to kick in'

Currently, he is company secretary and compliance officer at IDFC Ltd since May 24, 2019. In this role, Shah has been responsible for secretarial, governance, and compliance function for over 26 companies/entities of IDFC Group.

Prior to joining IDFC in 2001, Shah worked with International Paper Ltd for a period of six years as director of finance and company secretary, where he was in charge of the finance function and regulatory compliances.

Shah has worked as head of taxation in SKF Bearings India Ltd where he was responsible for direct and indirect taxation matters across India. He also worked for a short period with Pfizer Ltd as a finance officer.

Also Read: Twitter whistleblower: Spies for foreign agencies are on social media company's payroll

He completed his article-ship for CA with Bansi S. Mehta & Co, where he spent three years. Also, he is a qualified member of the Institute of Chartered Accountants of India (ICAI), the Institute of Cost & Management Accountants of India (ICWA), and the Institute of Company Secretaries of India (ICSI).

(Edited by : Shoma Bhattacharjee)

First Published:Aug 24, 2022 5:29 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Wolfspeed Shares Fall Sharply After Trading Resumes
Wolfspeed Shares Fall Sharply After Trading Resumes
Mar 28, 2025
10:04 AM EDT, 03/28/2025 (MT Newswires) -- Wolfspeed ( WOLF ) shares dropped past 45% in recent Friday trading following the resumption of trading that was paused due to volatility. On Thursday, the company announced the appointment of Robert Feurle as chief executive officer, effective May 1. Feurle succeeds Thomas Werner, who is serving as interim executive chairman and will...
BTG Pactual's Andre Esteves expected to join Eneva's board
BTG Pactual's Andre Esteves expected to join Eneva's board
Mar 28, 2025
SAO PAULO, March 28 (Reuters) - The chairman of Brazil's investment bank BTG Pactual, billionaire Andre Esteves, is expected to join the board of power generator Eneva , according to a proposal released on Friday for Eneva's shareholders' meeting. Under the proposal, Eneva's board of directors, composed of seven members, would see two new members as two others exit. Rodrigo...
Chile's Codelco swings to profit in 2024
Chile's Codelco swings to profit in 2024
Mar 28, 2025
SANTIAGO, March 28 (Reuters) - Chile's Codelco , the world's largest copper producer, on Friday reported a swing into the black for its 2024 earnings, posting a pre-tax profit of $790 million compared to a loss of $757 million the previous year. The state-owned miner said output totaled 1.328 million metric tons. ...
Liquidia Says FDA to Review New Drug Application for Yutrepia
Liquidia Says FDA to Review New Drug Application for Yutrepia
Mar 28, 2025
10:04 AM EDT, 03/28/2025 (MT Newswires) -- Liquidia ( LQDA ) said Friday the US Food and Drug Administration accepted its resubmitted new drug application for Yutrepia inhalation powder to treat pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. The company said the FDA classified the resubmission as a complete, Class 1 response to an August 2024...
Copyright 2023-2026 - www.financetom.com All Rights Reserved